Stay updated on Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial

Sign up to get notified when there's something new on the Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Added the condition Myelodysplastic/myeloproliferative neoplasm and removed Myeloproliferative neoplasm from the Conditions list; page revision updated to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-25T20:05:25.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2026-03-18T11:58:47.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3; no visible changes to the page content.
    Difference
    0.1%
    Check dated 2026-03-11T14:22:34.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    No additions or deletions detected; the page content appears unchanged.
    Difference
    0.1%
    Check dated 2026-03-04T10:43:15.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The update appears to be minor visual or formatting adjustments to the study page without altering the actual study details or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-18T04:15:05.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the page header. The funding-status notice and the previous v3.4.1 revision tag were removed.
    Difference
    0.3%
    Check dated 2026-02-11T02:04:27.000Z thumbnail image

Stay in the know with updates to Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial page.